Showing 1161-1170 of 3038 results for "".
Practical Recommendations for Monitoring Response to Amyloid-Targeting Treatments for Early Alzheimer Disease
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/practical-recommendations-for-monitoring-response-to-amyloid-targeting-treatments-for-early-alzheimer-disease/36189/The authors present practical recommendations for using cognitive assessments and amyloid PET scanning to monitor response to amyloid-targeting treatments in clinical practice.Neuropsychiatric Aspects of Alzheimer’s Disease
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/neuropsychiatric-aspects-of-alzheimers-disease/31538/Clinically significant neuropsychiatric symptoms need evidence-based treatment.Inpatient Rehabilitation Following Traumatic Brain Injury
https://practicalneurology.com/diseases-diagnoses/tbi/inpatient-rehabilitation-following-traumatic-brain-injury/31989/Unique care and benefits of inpatient rehabilitation facilities compared with other care settingsResumption of Anticoagulant Therapy Following Ischemic and Hemorrhagic Strokes: Indications and Timing
https://practicalneurology.com/diseases-diagnoses/stroke/resumption-of-anticoagulant-therapy-following-ischemic-and-hemorrhagic-strokes-indications-and-timing/31965/Resumption of anticoagulant in ischemic stroke or intracranial hemorrhage should be individualized.The Effects of Climate Change on Emerging Infections and the Global Landscape of Neuroinfectious Disease
https://practicalneurology.com/diseases-diagnoses/imaging-testing/the-effects-of-climate-change-on-emerging-infections-and-the-global-landscape-of-neuroinfectious-disease/32155/Climate change has direct and indirect effects that have altered the landscape of neuroinfectious disease and will continue to do so.Dementia Insights: Antiamyloid Antibody Therapy in Alzheimer Disease
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/dementia-insights-antiamyloid-antibody-therapy-in-alzheimer-disease/31928/The saga continues for development of antiamyloid monoclonal antibodies, aducanumab, lecanemab, donanemab, and gantenerumab for Alzheimer disease.Fatigue in Multiple Sclerosis: A Comprehensive Approach to Evaluation and Management
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/fatigue-in-multiple-sclerosis-a-comprehensive-approach-to-evaluation-and-management/32087/Management of fatigue in multiple sclerosis requires a holistic approach tailored to the individual.Toward Personalized Care for Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/toward-personalized-care-for-multiple-sclerosis/31754/Biomarkers and precision medicine are just part of individualizing care for a diverse population of people with multiple sclerosis.Stroke Snapshot: Carotid Artery Webs—Epidemiology and Pathophysiology
https://practicalneurology.com/diseases-diagnoses/stroke/stroke-snapshot-carotid-artery-webs-epidemiology-and-pathophysiology/32158/Carotid artery webs—nonatheromatous, shelf-like projections arising from the tunica intima of the posterior carotid wall—are suspected to be a cause of otherwise cryptogenic strokes.Multiple Sclerosis in the Black Population of the United States
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/multiple-sclerosis-in-the-black-population-of-the-united-states/31756/Black people with multiple sclerosis are affected by frequent relapses, early disability accrual, and rapid disease progression.